Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft--host disease after haploidentical allogeneic hematopoietic stem cell transplantation

Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft--host disease after haploidentical allogeneic hematopoietic stem cell transplantation

Purpose: Graft- versus -host disease (GVHD) is an important complication after human leukocyte antigen (HLA) haploidentical donor (HID) hematopoietic stem cell transplantation (HSCT), which may lead to poor prognosis. Our study intends to identify the efficacy and safety of mesenchymal stem cells (M...

Full description

Bibliographic Details
Main Authors: Meng-Zhu Shen, Xin-Xin Liu, Zhi-Yuan Qiu, Lan-Ping Xu, Xiao-Hui Zhang, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Si-Ning Liu, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Dong Mo
Format: Article
Language:English
Published: SAGE Publishing 2022-01-01
Series:Therapeutic Advances in Hematology
Online Access:https://doi.org/10.1177/20406207211072838

Internet

https://doi.org/10.1177/20406207211072838

Similar Items